Table 4.
Regions | Bioecological zones | Health district | Prevalence (%) | Geometric mean | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Before IVM MDA | Under IVM MDA | % reduction | χ 2 | P-value | Before IVM MDA | Under IVM MDA | % reduction | P-value | |||
South west | DERF | Mamfe | 64.60 | 49.73 | 23.02 | 0.7529 | 0.335 | 2,957.8 | 1,934.8 | 34.58 | < 0.0001 |
DHERF | 59.40 | 71.97 | -21.16 | 10.6411 | 0.001 | 5,800.9 | 5,743.6 | 0.99 | < 0.0001 | ||
North west | FS | Nwa | 0.20 | 0.50 | -150.00 | 0.0331 | 0.281 | 13.90 | 175.8 | -1164.74 | < 0.0001 |
Abbreviations: DERF deciduous equatorial rainforest, DHERF dense humid equatorial rainforest, FS forested savanna, IVM MDA ivermectin mass drug administration (χ 2 test was used to compare prevalence rates before and under treatment; t-test was used to compare mean intensity of infection before and under treatment)